{"id":"NCT01462929","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A Multiple Dose, Double-blind, Double-dummy, Placebo Controlled, Parallel Clinical Trial to Assess the Efficacy and Safety of Twice Daily Inhaled Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2012-03","completion":"2012-05","firstPosted":"2011-11-01","resultsPosted":"2013-05-22","lastUpdate":"2017-01-04"},"enrollment":414,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"Aclidinium bromide","otherNames":[]},{"type":"DRUG","name":"Tiotropium","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Aclidinium bromide","type":"EXPERIMENTAL"},{"label":"Tiotropium","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The aim of the present study is to evaluate the 24h bronchodilatory efficacy of inhaled aclidinium bromide 400 µg administered twice a day versus placebo and tiotropium bromide, respectively, after 6 weeks of treatment.","primaryOutcome":{"measure":"Change From Baseline in Normalised Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve Over the 24-h Period After 6 Weeks of Treatment","timeFrame":"Week 6","effectByArm":[{"arm":"Aclidinium Bromide 400 µg BID","deltaMin":0.065,"sd":0.017},{"arm":"Tiotropium 18 μg Once-daily","deltaMin":0.055,"sd":0.018},{"arm":"Placebo","deltaMin":-0.085,"sd":0.023}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":41,"countries":["Czechia","Germany","Hungary","Poland"]},"refs":{"pmids":["28074135"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=3975&filename=Synopsis-las39-Final.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":171},"commonTop":["Nasopharyngitis","Headache"]}}